BLFS Insider Trading
Insider Ownership Percentage: 2.20%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $4,979,016.72
BioLife Solutions Insider Trading History Chart
This chart shows the insider buying and selling history at BioLife Solutions by year and by quarter.
Skip ChartChart Data in Insider Trading History Table
BioLife Solutions Share Price & Price History
Current Price: $21.91
Price Change: ▼ Price Decrease of -0.35 (-1.57%)
As of 04/17/2025 05:00 PM ET
BioLife Solutions Insider Trading History
BioLife Solutions Institutional Trading History
Data available starting January 2016
BioLife Solutions, Inc. develops, manufactures, and markets bioproduction tools and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor Freeze Media that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; bioproduction tools, such as human platelet lysates for cell expansion and CellSeal closed system vials that are used in CGT; and the ThawSTAR line that comprises of a family of automated thawing devices for frozen cell and gene therapies packaged in cryovials and cryobags. The company also provides cryogenic freezer technology for controlled rate freezing and cryogenic storage of biologic materials; ultra-low temperature mechanical freezers; evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals; liquid nitrogen laboratory freezers, cryogenic equipment, and accessories; and biological and pharmaceutical storage and transport services. It markets and sells its products directly, as well as through third party distributors. The company was incorporated in 1987 and is headquartered in Bothell, Washington.
Read More on BioLife Solutions
Today's Range
Now: $21.91
52 Week Range
Now: $21.91
Volume
529,574 shs
Average Volume
375,729 shs
Market Capitalization
$1.04 billion
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.93
Who are the company insiders with the largest holdings of BioLife Solutions?
BioLife Solutions' top insider investors include:
- Casdin Partners Master Fund, L (Major Shareholder)
- Greef Roderick De (CEO)
- Michael Rice (CEO)
- Aby J Mathew (EVP)
- Troy Wichterman (CFO)
- Karen A Foster (Insider)
- Todd Berard (CMO)
- Garrie Richardson (CRO)
- Sarah Aebersold (Insider)
- Geraint Phillips (SVP)
- Marcus Schulz (CRO)
- Amy Duross (Director)
- Sean Werner (CTO)
Learn More about top insider investors at BioLife Solutions.
Who are the major institutional investors of BioLife Solutions?
Which institutional investors are selling BioLife Solutions stock?
During the last quarter, BLFS stock was sold by these institutional investors:
- Kings Path Partners LLC
Within the last year, company insiders that have sold BioLife Solutions company stock include:
- Casdin Partners Master Fund, L (Major Shareholder)
- Greef Roderick De (CEO)
- Michael Rice (CEO)
- Aby J Mathew (EVP)
- Troy Wichterman (CFO)
- Karen A Foster (Insider)
- Todd Berard (CMO)
- Garrie Richardson (CRO)
Learn More investors selling BioLife Solutions stock.
Which institutional investors are buying BioLife Solutions stock?
Within the last quarter, BLFS stock was bought by institutional investors including:
- GAMMA Investing LLC
- SG Americas Securities LLC
- GAMMA Investing LLC
- Rhumbline Advisers